GUTS.US Fractyl Health, Inc. Common Stock

Healthcare Health Care Equipment & Supplies USA Stocks
0.9036 USD
Close of Nov 15, 2026
0.8000 29.34
Market cap
USD 12.0M
P/E
-
P/B
5.06x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.

Is GUTS.US undervalued?

Graham number

The Graham number of Fractyl Health, Inc. Common Stock cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Fractyl Health, Inc. Common Stock fundamental analysis

No fundamental analysis for Fractyl Health, Inc. Common Stock yet.

Fractyl Health, Inc. Common Stock stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Fractyl Health, Inc. Common Stock

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. The company also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is desi…

Full company profile